Evaluation of a Personcentered Internet-based CBT Program for Stress, Anxiety and Depressive Symptoms in Patients With Cardiovascular Disease
Evaluation of an Adaptable and Personcentered Internet-based CBT Program Aimed to Treat Stress, Anxiety and Depressive Symptoms in Patients With Cardiovascular Disease
1 other identifier
interventional
215
1 country
1
Brief Summary
To evaluate a nine-week adaptable and person-centred I-CBT program that can be directed towards stress, anxiety and depressive symptoms in persons with CVD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2021
CompletedFirst Posted
Study publicly available on registry
January 27, 2021
CompletedStudy Start
First participant enrolled
March 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedNovember 24, 2025
November 1, 2025
2.3 years
January 22, 2021
November 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in stress from baseline to 9 weeks on the 10 item Perceived Stress Scale
The 10-item Perceived Stress Scale is a valideted self-report of Stress. The instreument measures the degree to which individuals perceives their life situations as stressful. The 10 items are rated on a 5 point scale and higher scores means more stress
From baseline to 9 weeks at the end of the intervention.
Change in anxiety from baseline to 9 weeks on the 7-item Generalized Anxiety Disorder Scale.
General Anxiety Disorder scale is validagted self-resport that measure symptoms of general anxiety during the last two weeks. The 7-items range from 0 (not bothered at all) to 3 (nearly every day). A higher score indicate more anxiety and the cut-off 5 suggests at least mild anxiety.
From baseline to 9 weeks at the end of the intervention.
Change in depressive symptoms from baseline to 9 weeks on the 9 item Patient Health Questionnaire.
The 9-item Patient Health Questionnaire is a validated self-report that measure depressive symtpoms during the last two weeks. Each item is answered on a four graded scale where 0 means that the person not is affected and 3 where the person is affected several Days to almost every day. Higher numbers represents higher levels of depressive symptoms. A cut-off \>5 represents at least mild depression.
From baseline to 9 weeks at the end of the intervention.
Study Arms (2)
Design of the CBT treatment content
EXPERIMENTALPatient determined CBT content (i.e. person-centered) vs. therapist determined I-CBT content
Control of support and feedback
EXPERIMENTALPatient-controlled support and feedback (person-centred) vs. therapist -controlled.
Interventions
When determining the content of the I-CBT program, the participants and therapist will be allowed to choose from a library of treatment modules. Therapist controlled support and feedback are given weekly and in a structured manner. Participants will be able to contact the therapist when support and feedback is desired
Eligibility Criteria
You may qualify if:
- age 18 years and above
- treatment for cardiovascular disease (CVD) according to European Society of Cardiology guidelines
- stable CVD (New York Heart Association class I-III) and not having been hospitalised for CVD in in the last four weeks.
- stress (Perceived Stress Scale (PSS)-10\>13 points) and/or
- anxiety (i.e. General Anxiety Disorder Scale (GAD) ≥5 points) and/or
- depressive symptoms (Patient Health Questionnaire-9 28 (PHQ-9) \> 5 points)
You may not qualify if:
- severe CVD (New York Heart Association classification IV) or another severe chronic life-threatening disease
- severe stress, anxiety or depression assessed as requiring acute treatment
- not being able to dedicate 3-4 hours per week to participate in the program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peter Johansson
Norrköping, Linköpings Universitet, 601 74, Sweden
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Johansson, Ph.D
Department of Health, Medicine and Caring Sciences, Linkoping University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 22, 2021
First Posted
January 27, 2021
Study Start
March 13, 2023
Primary Completion
June 30, 2025
Study Completion
June 30, 2025
Last Updated
November 24, 2025
Record last verified: 2025-11